Product Description: 3-Fluoro-evodiamine glucose (Compound 8) is an evodiamine-glucose conjugate. 3-Fluoro-evodiamine glucose activates the expression of glucose transporter 1 (GLUT1), and inhibits topoisomerase I/II. 3-Fluoro-evodiamine glucose induces apoptosis and arrests the cell cycle at G2/M phase. 3-Fluoro-evodiamine glucose exhibits antitumor efficacy in vivo and in vitro, without significant toxicity[1].
Applications: Cancer-programmed cell death
Formula: C25H26FN3O7
References: [1]Wu Z, et al., Design of Evodiamine-Glucose Conjugates with Improved In Vivo Antitumor Activity. J Med Chem. 2024 May 9;67(9):7373-7384.
Molecular Weight: 499.49
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Apoptosis;GLUT;Topoisomerase